Advertisement

Botulinumtoxin bei kosmetischen Indikationen

  • Martina Kerscher

Zusammenfassung

Nach Ergebnissen einer Befragung im Sommer 2001 führen nahezu 80% deutscher Hautkliniken Behandlungen mit Botulinumtoxin durch (Abb. 7.1).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Arznei-Telegramm (2003) 34 (4):39Google Scholar
  2. 2.
    Baumann L (2002) Cosmetic Dermatology Principles and Practice. Mc Graw Hill, New YorkGoogle Scholar
  3. 3.
    Blitzer A, Binder WJ (2001) Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Facial Plast Surg Clin North Am 9: 95–404Google Scholar
  4. 4.
    Blitzer A, Brin MF, Keen MF, Aviv JE (1993) Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 119: 1018–1022PubMedCrossRefGoogle Scholar
  5. 5.
    Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF (1997) The management of hyperfunctional facial lines with botulinum toxin. Arch Otolaryngol Head Neck Surg 123: 389–392PubMedGoogle Scholar
  6. 6.
    Botox ® (2000) Fachinformation. Merz PharmaGoogle Scholar
  7. 7.
    Brandt FS, Bellman B (1998) Cosmetic use of botulinum A exotoxin for the aging neck. Dermatol Surg 24: 1232–1234PubMedCrossRefGoogle Scholar
  8. 8.
    Breit S, Heckmann M (2000) Botulinumtoxin. Ein Neurotoxin zur dermatologischen Therapie. Hautarzt 51: 874–889Google Scholar
  9. 9.
    Brin MF, Lew MF, Adler CH et al (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type-A-resistent cervical dystonia. Neurology 53: 1431–1438PubMedCrossRefGoogle Scholar
  10. 10.
    Bushara KO, Jones JW, Park DM, Schutta HS (1995) Botulinum toxin and sweating. Mov Disord 10: 391Google Scholar
  11. 11.
    Carucci JA, Zweibel SM (2001) Botulinum A exotoxin for rejuvenation of the upper third of the face. Facial Plast Surg 17: 11–20PubMedCrossRefGoogle Scholar
  12. 12.
    Carruthers A, Carruthers J (1990) The treatment of glabellar furrows with botulinumtoxin A exotoxin. J Dermatol Surg Oncol 16: 83Google Scholar
  13. 13.
    Carruthers A, Carruthers J (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol, 18: 17–21PubMedCrossRefGoogle Scholar
  14. 14.
    Carruthers A, Carruthers J (1998) History of the cosmetic use of botulinumtoxin A exotoxin. Dermatol Surg 24: 1168–1171PubMedCrossRefGoogle Scholar
  15. 15.
    Carruthers J, Carruthers A (1998) The adjunctive usage of botulinum toxin. Dermatol Surg 24: 1244–1247PubMedCrossRefGoogle Scholar
  16. 16.
    Carruthers A, Carruthers J (2001) Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 20: 71–84PubMedCrossRefGoogle Scholar
  17. 17.
    Dysport ® (2002) Fachinformation. Ipsen PharmaGoogle Scholar
  18. 18.
    Garcia A, Fulton JE (1996) Cosmetic denervatation of the muscles of facial expression with botulinum toxin. Dermatol Surg, 22: 39–43PubMedCrossRefGoogle Scholar
  19. 19.
    Glogau RG (1998) Botulinum A neurotoxin for axillary hyperhidrosis: No sweat Botox®. Dermatol Surg, 24: 817–819Google Scholar
  20. 20.
    Hankins CL, Strimling R, Rogers GS (1998) Botulinum A toxin for glabellar wrinkles: dose and response. Dermatol Surg, 24: 1181–1183PubMedCrossRefGoogle Scholar
  21. 21.
    Heckmann M, Rzany B (2002) Botulinumtoxin in der Dermatologie. Grundlagen und praktische Anwendung. Urban und Vogel, MünchenGoogle Scholar
  22. 22.
    Huang W, Foster JA, Rogachefsky AS (2000) Pharmacology of botulinum toxin. J Am Acad Dermatol 43: 249–259PubMedCrossRefGoogle Scholar
  23. 23.
    Kerscher M, Weidmann MJ, Gottlöber P, Peter RU (2001) Botulinumtoxin A in der Faltenbildung. Dt Ärztebl 26: 1400–1402Google Scholar
  24. 24.
    Klein AW (1998) Dilution and storage of botulinum toxin. Dermatol Surg 24: 1179–1180PubMedCrossRefGoogle Scholar
  25. 25.
    Klein AW (2001) Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 20: 109–120PubMedCrossRefGoogle Scholar
  26. 26.
    Le Louarn C (2001) Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plast Surg 25: 73–84PubMedCrossRefGoogle Scholar
  27. 27.
    Leuchs J (1910) Beiträge zur Kenntnis des Toxins und Antitoxins des Bacillus botulinus. Z Hyg Infektionskrankh 65: 55–84CrossRefGoogle Scholar
  28. 28.
    Lowe NJ, Maxwell A, Harper H (1996) Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 35: 569–572PubMedCrossRefGoogle Scholar
  29. 29.
    Lowe NJ (1998) Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Dermatol Surg 24: 1216–1218PubMedCrossRefGoogle Scholar
  30. 30.
    Markey AC (2000) Botulinum A exotoxin in cosmetic dermatology. Clin Exp Dermatol 25: 173–175CrossRefGoogle Scholar
  31. 31.
    Matarasso SL (1998) Complications of Botulinum A Exotoxin for Hyperfunctional Lines. Dermatol Surg 24: 1249–1254PubMedCrossRefGoogle Scholar
  32. 32.
    Moyer E, Setler PE (1994) Botulinum toxin type B: experimental and clinical experience. In: Jan-kovik J, Hallet M (eds) Therapy with Botulinum Toxin. Marcel Dekker, New YorkGoogle Scholar
  33. 33.
    Naumann M, Hefter H, Heinen F (1998) Botulinumtoxin. Wirkprinzip und klinische Anwendung. Uni-Med Verlag, BremenGoogle Scholar
  34. 34.
    NeuroBloc® (2001) Fachinformation. Elan PharmaGoogle Scholar
  35. 35.
    NeuroBloc ® (2001) Produktmonographie. Elan PharmaGoogle Scholar
  36. 36.
    Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alterative to strabismus surgery. Ophthalmology 87: 1044–1049PubMedGoogle Scholar
  37. 37.
    Scott AB (1989) Clostridial toxins as therapeutic agents. In: Simpson LL (ed) Botulinum Neuro-toxin and Tetanus Toxin. Academic Press, New York, pp 399–412Google Scholar
  38. 38.
    Shelley WB, Talanin NY, Shelley ED. (1998) Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol, 38: 227–229PubMedCrossRefGoogle Scholar
  39. 39.
    Sommer B, Sattler G (Hrsg). (2001) Botulinumtoxin in der ästhetischen Medizin. Blackwell Verlag, Berl in WienGoogle Scholar
  40. 40.
    Van Ermengen E (1897) Über einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg Infektionskrankh 26: 1–56Google Scholar
  41. 41.
    Williams SC, Kimmig W, Moll I, Kerscher MJ (2003) Einsatz dermatokosmetischer Verfahren an deutschen Hautkliniken.–Ergebnisse einer nationalen Umfrage. JDDG 1: 910–914Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Martina Kerscher
    • 1
  1. 1.Studiengang Kosmetik und KörperpflegeUniversität HamburgHamburgDeutschland

Personalised recommendations